Antigen engineering can play a critical role in the protective immunity elicited by Yersinia pestis DNA vaccines

S Wang, I Mboudjeka, JD Goguen, S Lu - Vaccine, 2010 - Elsevier
The use of a DNA immunization approach to deliver protective antigens against Yersinia
pestis (Y. pestis) has been successful in previously reported studies. In the current study, the …

[HTML][HTML] Plague vaccine development: current research and future trends

SK Verma, U Tuteja - Frontiers in immunology, 2016 - frontiersin.org
Plague is one of the world's most lethal human diseases caused by Yersinia pestis, a Gram-
negative bacterium. Despite overwhelming studies for many years worldwide, there is no …

Plague vaccines and the molecular basis of immunity against Yersinia pestis

LE Quenee, O Schneewind - Human vaccines, 2009 - Taylor & Francis
Yersinia pestis is the causative agent of bubonic and pneumonic plague, human diseases
with high mortality. Due to the microbe's ability to spread rapidly, plague epidemics present …

Protection against pneumonic plague following oral immunization with a non-replicating vaccine

A Jones, C Bosio, A Duffy, A Goodyear, M Schriefer… - Vaccine, 2010 - Elsevier
Yersinia pestis is a dangerous bacterial pathogen that when inhaled can rapidly induce fatal
pneumonic plague. Thus, there is a need for stable, safe, and easily administered mucosal …

Gamma interferon, tumor necrosis factor alpha, and nitric oxide synthase 2, key elements of cellular immunity, perform critical protective functions during humoral …

MA Parent, LB Wilhelm, LW Kummer… - Infection and …, 2006 - Am Soc Microbiol
Pulmonary infection by Yersinia pestis causes pneumonic plague, a rapidly progressing and
often fatal disease. To aid the development of safe and effective pneumonic plague …

[HTML][HTML] An Encapsulated Yersinia pseudotuberculosis Is a Highly Efficient Vaccine against Pneumonic Plague

A Derbise, A Cerdà Marín, P Ave… - PLoS neglected …, 2012 - journals.plos.org
Background Plague is still a public health problem in the world and is re-emerging, but no
efficient vaccine is available. We previously reported that oral inoculation of a live attenuated …

Yersinia pestis biovar Microtus strain 201, an avirulent strain to humans, provides protection against bubonic plague in rhesus macaques

Q Zhang, Q Wang, G Tian, Z Qi, X Zhang… - Human Vaccines & …, 2014 - Taylor & Francis
Yersinia pestis biovar Microtus is considered to be a virulent to larger mammals, including
guinea pigs, rabbits and humans. It may be used as live attenuated plague vaccine …

Combinational deletion of three membrane protein-encoding genes highly attenuates Yersinia pestis while retaining immunogenicity in a mouse model of pneumonic …

BL Tiner, J Sha, ML Kirtley, TE Erova… - Infection and …, 2015 - Am Soc Microbiol
Previously, we showed that deletion of genes encoding Braun lipoprotein (Lpp) and MsbB
attenuated Yersinia pestis CO92 in mouse and rat models of bubonic and pneumonic …

Plague vaccines: current developments and future perspectives

VA Feodorova, VL Motin - Emerging microbes & infections, 2012 - Taylor & Francis
Despite many decades of intensive studies of Yersinia pestis, the causative agent of plague,
there is no safe and efficient vaccine against this devastating disease. A recently developed …

The Resistance of BALB/cJ Mice to Yersinia pestis Maps to the Major Histocompatibility Complex of Chromosome 17

JK Turner, MM McAllister, JL Xu… - Infection and …, 2008 - Am Soc Microbiol
Yersinia pestis, the causative agent of plague, has been well studied at the molecular and
genetic levels, but little is known about the role that host genes play in combating this highly …